C4 Therapeutics (CCCC) Earnings Date, Estimates & Call Transcripts $6.04 +0.07 (+1.17%) (As of 11/7/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends C4 Therapeutics Latest Earnings SummaryUpcoming Earnings DateFeb. 27EstimatedActual EPS (Oct. 31) -$0.35 Beat By $0.05 Consensus EPS (Oct. 31) -$0.40 C4 Therapeutics issued Q3 2024 earnings on October 31, 2024, reporting an EPS of -$0.35, which beat analysts' consensus estimates of -$0.40 by $0.05. Quarterly revenue was reported to be $15.36 million, above analyst estimates of $5.95 million. With a trailing EPS of -$1.70, C4 Therapeutics' earnings are expected to decrease next year, from ($1.52) to ($1.64) per share. CCCC Upcoming EarningsC4 Therapeutics' next earnings date is estimated for Thursday, February 27, 2025, based off prior year's reporting schedules. Get C4 Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on C4 Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCCCC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CCCC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressCould TSLA reach $500 a share? Free ebook says it’s possible.Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link C4 Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.43-$0.43-$0.43Q2 20241-$0.42-$0.42-$0.42Q3 20241-$0.34-$0.34-$0.34Q4 20241-$0.74-$0.74-$0.74FY 20244($1.93)($1.93)($1.93) C4 Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/27/2025(Estimated)------- 10/31/2024--$0.40-$0.35+$0.05-$0.35$5.95M$15.36M8/1/2024--$0.37-$0.26+$0.11-$0.26$6.88M$12.01M5/8/2024Q1 2024-$0.41-$0.41--$0.41$10.93M$3.04M 2/22/2024Q4 2023-$0.67-$0.68 -$0.01-$0.68$5.23M$3.26M 11/1/2023Q3 2023-$0.65-$0.55+$0.10-$0.55$6.94M$11.07M 8/8/2023Q2 2023-$0.74-$0.73+$0.01-$0.73$8.65M$2.66M Get the Latest News and Ratings for CCCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for C4 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/4/2023Q1 2023-$0.78-$0.71+$0.07-$0.71$6.71M$3.76M 2/23/2023Q4 2022-$0.72-$0.76 -$0.04-$0.76$8.56M$2.85M C4 Therapeutics Earnings - Frequently Asked Questions When is C4 Therapeutics's earnings date? C4 Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates. Learn more on CCCC's earnings history. Did C4 Therapeutics beat their earnings estimates last quarter? In the previous quarter, C4 Therapeutics (NASDAQ:CCCC) reported ($0.35) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.40) by $0.05. Learn more on analysts' earnings estimate vs. CCCC's actual earnings. How much revenue does C4 Therapeutics generate each year? C4 Therapeutics (NASDAQ:CCCC) has a recorded annual revenue of $20.76 million. How much profit does C4 Therapeutics generate each year? C4 Therapeutics (NASDAQ:CCCC) has a recorded net income of -$132.49 million. CCCC has generated -$1.70 earnings per share over the last four quarters. What is C4 Therapeutics's EPS forecast for next year? C4 Therapeutics's earnings are expected to decrease from ($1.52) per share to ($1.64) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies ALEC Earnings Date INBX Earnings Date CGEN Earnings Date RCKT Earnings Date NTLA Earnings Date SPRY Earnings Date XNCR Earnings Date AVDL Earnings Date ARDX Earnings Date RCUS Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Could TSLA reach $500 a share? Free ebook says it’s possible. (Ad)Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link This page (NASDAQ:CCCC) was last updated on 11/7/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredStrange new catalyst for gold ($5,000 possible?)Gold: Now legal tender Most Americans missed this big story, but 1 in 5 states have now made gold and silve...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share C4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
